Rauch Andri, James Ian, Pfafferott Katja, Nolan David, Klenerman Paul, Cheng Wendy, Mollison Lindsay, McCaughan Geoff, Shackel Nick, Jeffrey Gary P, Baker Ross, Freitas Elizabeth, Humphreys Isla, Furrer Hansjakob, Günthard Huldrych F, Hirschel Bernard, Mallal Simon, John Mina, Lucas Michaela, Barnes Eleanor, Gaudieri Silvana
University Clinic of Infectious Diseases, University Hospital Bern and University of Bern, Bern, Switzerland.
Hepatology. 2009 Oct;50(4):1017-29. doi: 10.1002/hep.23101.
Many hepatitis C virus (HCV) infections worldwide are with the genotype 1 and 3 strains of the virus. Cellular immune responses are known to be important in the containment of HCV genotype 1 infection, and many genotype 1 T cell targets (epitopes) that are presented by host human leukocyte antigens (HLAs) have been identified. In contrast, there is almost no information known about the equivalent responses to genotype 3. Immune escape mechanisms used by HCV include the evolution of viral polymorphisms (adaptations) that abrogate this host-viral interaction. Evidence of HCV adaptation to HLA-restricted immune pressure on HCV can be observed at the population level as viral polymorphisms associated with specific HLA types. To evaluate the escape patterns of HCV genotypes 1 and 3, we assessed the associations between viral polymorphisms and specific HLA types from 187 individuals with genotype 1a and 136 individuals with genotype 3a infection. We identified 51 HLA-associated viral polymorphisms (32 for genotype 1a and 19 for genotype 3a). Of these putative viral adaptation sites, six fell within previously published epitopes. Only two HLA-associated viral polymorphisms were common to both genotypes. In the remaining sites with HLA-associated polymorphisms, there was either complete conservation or no significant HLA association with viral polymorphism in the alternative genotype. This study also highlights the diverse mechanisms by which viral evasion of immune responses may be achieved and the role of genotype variation in these processes.
There is little overlap in HLA-associated polymorphisms in the nonstructural proteins of HCV for the two genotypes, implying differences in the cellular immune pressures acting on these viruses and different escape profiles. These findings have implications for future therapeutic strategies to combat HCV infection, including vaccine design.
全球许多丙型肝炎病毒(HCV)感染是由该病毒的1型和3型毒株引起的。已知细胞免疫反应在控制HCV 1型感染中很重要,并且已经鉴定出许多由宿主人类白细胞抗原(HLA)呈递的1型T细胞靶标(表位)。相比之下,关于对3型的等效反应几乎一无所知。HCV使用的免疫逃逸机制包括病毒多态性(适应性)的演变,这种演变消除了这种宿主-病毒相互作用。在人群水平上可以观察到HCV适应HLA限制的免疫压力的证据,表现为与特定HLA类型相关的病毒多态性。为了评估HCV 1型和3型的逃逸模式,我们评估了187例1a型感染个体和136例3a型感染个体中病毒多态性与特定HLA类型之间的关联。我们鉴定出51种与HLA相关的病毒多态性(1a型为32种,3a型为19种)。在这些假定的病毒适应位点中,有六个位于先前发表的表位内。两种基因型仅共有两种与HLA相关的病毒多态性。在其余具有与HLA相关多态性的位点中,要么完全保守,要么在另一种基因型中病毒多态性与HLA无显著关联。这项研究还强调了病毒逃避免疫反应可能实现的多种机制以及基因型变异在这些过程中的作用。
两种基因型的HCV非结构蛋白中与HLA相关的多态性几乎没有重叠,这意味着作用于这些病毒的细胞免疫压力不同,逃逸模式也不同。这些发现对未来对抗HCV感染的治疗策略具有启示意义,包括疫苗设计。